Next Article in Journal / Special Issue
Teenagers as a Moving Target: How Can Teenagers Be Encouraged to Accept Treatment?
Previous Article in Journal
Aligning the Economic Value of Companion Diagnostics and Stratified Medicines
Previous Article in Special Issue
Individual Oral Therapy with Immediate Release and Effervescent Formulations Delivered by the Solid Dosage Pen
J. Pers. Med. 2012, 2(4), 267-276; doi:10.3390/jpm2040267
Article

Pattern of Timing Adherence Could Guide Recommendations for Personalized Intake Schedules

1,* , 1
, 2
, 3
 and 1
1 Pharmaceutical Care Research Group, Department of Pharmaceutical Sciences, University of Basel, Pharmazentrum, Klingelbergstrasse 50, CH-4056 Basel, Switzerland 2 Vascular Risk Foundation VARIFO, Ziegelfeldstrasse 1, CH-4600 Olten, Switzerland 3 Diagnostic Hematology, University Hospital of Basel, Petersgraben 4, CH-4031 Basel, Switzerland
* Author to whom correspondence should be addressed.
Received: 24 September 2012 / Revised: 22 November 2012 / Accepted: 23 November 2012 / Published: 28 November 2012
(This article belongs to the Special Issue Dosage Personalization in Modern Medicine)
View Full-Text   |   Download PDF [465 KB, uploaded 28 November 2012]   |   Browse Figure

Abstract

Deviations in execution from the prescribed drug intake schedules (timing non adherence) are frequent and may pose a substantial risk for therapeutic failure. Simple methods to monitor timing adherence with multiple drugs are missing. A new technology, i.e., the polymedication electronic monitoring system (POEMS) attached to a multidrug punch card, was used in a clinical trial on outpatients with prescribed medicines for vascular risk reduction. The complete delineation of timing adherence allows for the calculation of objective adherence parameters and the linking of exposure with drug-drug interactions. A sub-analysis was performed on 68 patients, who were prescribed lipid lowering therapy. A smaller intake time variability of the lipid lowering drug was significantly associated with better levels of LDL-cholesterol, independently of the time of day. This finding may challenge current general recommendations for the timing of lipid lowering drugs’ intake and substantiate that inter-individual differences in timing adherence may contribute to response variability. Thus, objective parameters based on multidrug adherence monitoring should be considered as independent variables in personalized medicine. In clinical practice, personalized intake recommendations according to patients’ pattern of timing adherence may help to optimize the effectiveness of lipid lowering agents.
Keywords: compliance; adherence; time variability; electronic polymedication monitoring; lipid lowering agents compliance; adherence; time variability; electronic polymedication monitoring; lipid lowering agents
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Export to BibTeX |
EndNote


MDPI and ACS Style

Walter, P.; Arnet, I.; Romanens, M.; Tsakiris, D.A.; Hersberger, K.E. Pattern of Timing Adherence Could Guide Recommendations for Personalized Intake Schedules. J. Pers. Med. 2012, 2, 267-276.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert